NEWS

Aug 12, 2014
On Thursday, August 21st from 4-6:30pm pm there will be an open house for the fall courses in the...
Jul 29, 2014
A new funding opportunity announcement (FOA) is available to move commercially viable diagnostic...
Jan 9, 2014
NIH-OTT authors report in Nature Biotechnology (Jan 2014) an analysis of FDA approved drugs and...
Jan 9, 2014
The OTT is pleased to announce that the annual report for Fiscal Year 2013 is now available for...
Aug 30, 2013
The Office of Intramural Research, Office of the Director, NIH, invites you to the eighth annual...

New Opportunities


Available for licensing are several potent and selective inhibitors of IL-10 and IFN-gamma signaling. Although cytokines play important roles in cancer and...


The tumor suppressor protein p53 regulates the self-renewal and pluripotency of normal and cancer stems cells, as well as the efficiency of reprogramming normal...


Glioblastoma Multiforme (GBM) is the most common and malignant type of primary brain tumor in humans. Despite existing conventional therapies, including initial...